Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

• Alba Llibre,
• Nikaïa Smith,
• Vincent Rouilly,
• Munyaradzi Musvosvi,
• Elisa Nemes,
• Céline Posseme,
• Simbarashe Mabwe,
• Bruno Charbit,
• Stanley Kimbung Mbandi,
• Elizabeth Filander,
• Hadn Africa,
• Violaine Saint-André,
• Violaine Saint-André,
• Vincent Bondet,
• Pierre Bost,
• Pierre Bost,
• Humphrey Mulenga,
• Nicole Bilek,
• Matthew L. Albert,
• Thomas J. Scriba,
• Darragh Duffy,
• Darragh Duffy

Affiliations

Alba Llibre

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France

Nikaïa Smith

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France

Vincent Rouilly

DATACTIX, Paris, France

Munyaradzi Musvosvi

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Elisa Nemes

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Céline Posseme

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France

Simbarashe Mabwe

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Bruno Charbit

Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, Université Paris Cité, Paris, France

Stanley Kimbung Mbandi

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Elizabeth Filander

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Hadn Africa

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Violaine Saint-André

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France

Violaine Saint-André

Bioinformatics and Biostatistics HUB, Computational Biology Department, Institut Pasteur, Université Paris Cité, Paris, France

Vincent Bondet

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France

Pierre Bost

Sorbonne Université, Complexité du vivant, Paris, France

Pierre Bost

Systems Biology Group, Computational Biology Department, Institut Pasteur, Université Paris Cité, Paris, France

Humphrey Mulenga

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Nicole Bilek

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Matthew L. Albert

HIBIO, San Francisco, CA, United States

Thomas J. Scriba

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Darragh Duffy

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France

Darragh Duffy

Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, Université Paris Cité, Paris, France